Tema Heart & Health ETF (HRTS)
$35.80
▼ -0.05 (-0.13%)
1-day change
$31.64 – $38.87
52-week range
Holdings data is not available for this fund yet.
HRTS Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Performance as of Oct. 2, 2026
| Period | Price return | Total return |
|---|---|---|
| 1M | ▼ -5.31% | ▼ -5.31% |
| 3M | ▲ +2.96% | ▲ +2.96% |
| 6M | ▲ +2.96% | ▲ +2.96% |
| YTD | ▲ +1.46% | ▲ +1.46% |
| 1Y | ▲ +12.29% | ▲ +13.82% |
| 3Y | · | · |
| 5Y | · | · |
| Max | ▲ +3.12% | ▲ +6.04% |
Volatility 1Y17.46%
Volatility 3Y·
Max drawdown 3Y
·
Beta 3Y·
Sharpe 1Y*1.25
Total return assumes dividends are reinvested. Returns are not benchmarked against an index. * Sharpe ratio is computed with a 0% risk-free rate.
Fund flows (SEC-reported)
Last month (May 2026)
+$672K
Quarter ending May 2026
-$698K
Trailing 12 months
-$10.5M
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Full composition 45 holdings
| Name | CUSIP | Value | % | Balance | Category | Country |
|---|---|---|---|---|---|---|
| Eli Lilly & Co | 532457108 | $6.0M | 11.52 | 5,413 | EC | US |
| UnitedHealth Group Inc | 91324P102 | $2.7M | 5.24 | 7,159 | EC | US |
| Novo Nordisk A/S | · | $2.7M | 5.24 | 59,455 | EC | DK |
| Roche Holding AG | 771195104 | $2.3M | 4.50 | 44,538 | EC | CH |
| Merck & Co Inc | 58933Y105 | $2.2M | 4.27 | 18,672 | EC | US |
| AstraZeneca PLC | · | $2.1M | 4.00 | 11,178 | EC | GB |
| Thermo Fisher Scientific Inc | 883556102 | $2.1M | 3.97 | 4,185 | EC | US |
| Johnson & Johnson | 478160104 | $1.9M | 3.59 | 8,274 | EC | US |
| Gilead Sciences Inc | 375558103 | $1.8M | 3.43 | 13,261 | EC | US |
| Novartis AG | · | $1.8M | 3.38 | 11,627 | EC | CH |
| Revolution Medicines Inc | 76155X100 | $1.7M | 3.33 | 10,971 | EC | US |
| Vertex Pharmaceuticals Inc | 92532F100 | $1.5M | 2.93 | 3,398 | EC | US |
| Danaher Corp | 235851102 | $1.4M | 2.66 | 7,557 | EC | US |
| Abbott Laboratories | 002824100 | $1.4M | 2.61 | 15,809 | EC | US |
| Bridgebio Pharma Inc | 10806X102 | $1.3M | 2.59 | 20,327 | EC | US |
| Cytokinetics Inc | 23282W605 | $1.3M | 2.52 | 17,069 | EC | US |
| AbbVie Inc | 00287Y109 | $1.2M | 2.40 | 5,714 | EC | US |
| Bristol-Myers Squibb Co | 110122108 | $1.1M | 2.09 | 18,939 | EC | US |
| Teva Pharmaceutical Industries | 881624209 | $1.1M | 2.06 | 30,273 | EC | IL |
| Dexcom Inc | 252131107 | $996K | 1.92 | 13,512 | EC | US |
| Amgen Inc | 031162100 | $992K | 1.91 | 2,946 | EC | US |
| Medtronic PLC | · | $975K | 1.88 | 13,203 | EC | IE |
| Edwards Lifesciences Corp | 28176E108 | $907K | 1.75 | 10,488 | EC | US |
| McKesson Corp | 58155Q103 | $888K | 1.71 | 1,196 | EC | US |
| Regeneron Pharmaceuticals Inc | 75886F107 | $866K | 1.67 | 1,408 | EC | US |
| Madrigal Pharmaceuticals Inc | 558868105 | $755K | 1.45 | 1,519 | EC | US |
| Boston Scientific Corp | 101137107 | $738K | 1.42 | 15,285 | EC | US |
| Chugai Pharmaceutical Co Ltd | · | $690K | 1.33 | 13,915 | EC | JP |
| Intuitive Surgical Inc | 46120E602 | $675K | 1.30 | 1,590 | EC | US |
| Alnylam Pharmaceuticals Inc | 02043Q107 | $590K | 1.14 | 1,954 | EC | US |
| Arrowhead Pharmaceuticals Inc | 04280A100 | $564K | 1.09 | 7,240 | EC | US |
| Scholar Rock Holding Corp | 80706P103 | $476K | 0.92 | 9,647 | EC | US |
| Xenon Pharmaceuticals Inc | 98420N105 | $459K | 0.88 | 8,393 | EC | CA |
| Ionis Pharmaceuticals Inc | 462222100 | $428K | 0.83 | 5,599 | EC | US |
| Insulet Corp | 45784P101 | $411K | 0.79 | 2,835 | EC | US |
| Ascendis Pharma A/S | · | $393K | 0.76 | 1,755 | EC | DK |
| First American Treasury Obliga | 31846V328 | $373K | 0.72 | 373,497 | STIV | US |
| Insmed Inc | 457669307 | $369K | 0.71 | 3,449 | EC | US |
| Stoke Therapeutics Inc | 86150R107 | $311K | 0.60 | 10,049 | EC | US |
| Viking Therapeutics Inc | 92686J106 | $280K | 0.54 | 8,538 | EC | US |
| MBX Biosciences Inc | 55287L101 | $276K | 0.53 | 8,761 | EC | US |
| Zealand Pharma A/S | · | $268K | 0.52 | 5,293 | EC | DK |
| Gubra A/S | · | $250K | 0.48 | 4,487 | EC | DK |
| Intellia Therapeutics Inc | 45826J105 | $195K | 0.38 | 13,892 | EC | US |
| Structure Therapeutics Inc | 86366E106 | $180K | 0.35 | 4,583 | EC | US |
Dividends 2 payments
1.32%TTM yield
$0.47TTM payout / share
Annual
(est.)
| Ex-date | Amount / share |
|---|---|
| Dec. 10, 2025 | $0.4730 |
| Dec. 11, 2024 | $0.4690 |
Institutional owners (13F) 18 filers
Institutions that report holding this ETF in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | % of tracked 13F | Shares | Type | As of |
|---|---|---|---|---|---|
| Sterling Investment Advisors, Ltd. | $4,511,060 | 45.88% | 124,360 | Shares | June 30, 2026 |
| STIFEL FINANCIAL CORP | $989,163 | 10.06% | 27,269 | Shares | June 30, 2026 |
| OLIVER LAGORE VANVALIN INVESTMENT GROUP | $904,563 | 9.20% | 30,841 | Shares | June 30, 2025 |
| UBS Group AG | $788,669 | 8.02% | 21,742 | Shares | June 30, 2026 |
| RAYMOND JAMES FINANCIAL INC | $698,895 | 7.11% | 19,267 | Shares | June 30, 2026 |
| CITADEL ADVISORS LLC | $453,428 | 4.61% | 12,500 | Shares | June 30, 2026 |
| HighTower Advisors, LLC | $368,183 | 3.74% | 10,150 | Shares | June 30, 2026 |
| JANE STREET GROUP, LLC | $337,967 | 3.44% | 9,317 | Shares | June 30, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $317,399 | 3.23% | 8,750 | Shares | June 30, 2026 |
| LPL Financial LLC | $219,676 | 2.23% | 6,056 | Shares | June 30, 2026 |
| ROYAL BANK OF CANADA | $156,000 | 1.59% | 4,283 | Shares | June 30, 2026 |
| Frazier Financial Advisors, LLC | $63,480 | 0.65% | 1,750 | Shares | June 30, 2026 |
| MORGAN STANLEY | $12,769 | 0.13% | 352 | Shares | June 30, 2026 |
| JONES FINANCIAL COMPANIES LLLP | $5,429 | 0.06% | 150 | Shares | June 30, 2026 |
| Global Retirement Partners, LLC | $5,115 | 0.05% | 141 | Shares | June 30, 2026 |
| Abound Wealth Management | $742 | 0.01% | 22 | Shares | March 31, 2026 |
| Harbor Asset Planning, Inc. | $544 | 0.01% | 15 | Shares | June 30, 2026 |
| BANK OF MONTREAL /CAN/ | $91 | 0.00% | 3 | Shares | June 30, 2026 |